My Cart

Fluorescent Human CCR9 Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Qty
CC9-HF2G3-20ug
$620.00
CC9-HF2G3-100ug
$1235.00
CC9-HF2G3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    C-C motif chemokine receptor 9, GPR28, CDw199, GPR-9-6, CC-CKR-9

  • Source

    Fluorescent Human CCR9 Full Length Protein (VLP) (CC9-HF2G3) is expressed from human 293 cells (HEK293). It contains AA Thr 2 - Leu 369 (Accession # P51686-1).

    Predicted N-terminus: Asp

  • Molecular Characterization

    This protein carries a GFP tag.

    *The isotype control of empty/mock VLP (Cat. No. VLP-NF2P4) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Conjugate

    GFP

    Excitation source: 488 nm spectral line, argon-ion laser

    Excitation Wavelength: 488 nm

    Emission Wavelength: 530 nm

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     CCR9 ELISA

    Immobilized Fluorescent Human CCR9 Full Length Protein (VLP) (Cat. No. CC9-HF2G3) at 5 μg/mL (100 μL/well) can bind Monclonal anti-CCR9 Antibody, Mouse lgG2a with a linear range of 1-31 ng/mL (QC tested).

    Protocol
  • Identity-DLS

     CCR9 DLS

    The mean peak Radius of VLP is 60-80 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

CCR9 is a chemokine receptor that directs lymphocyte trafficking to the intestine via its ligand CCL25. It plays a critical role in gut immune homeostasis and inflammatory bowel disease. Overexpression in various cancers, particularly T-cell acute lymphoblastic leukemia and gastrointestinal tumors, positions CCR9 as a promising therapeutic target.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland